|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
4 months to Sep 30, 2023
|
|
|---|---|---|---|
| Operating activities: | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash used in operating activities: | |||
| Net unrealized (appreciation) depreciation | |||
| Net realized (gains) losses | |||
| PIK interest income | |||
| Accretion of original issue discount on investments | |||
| Amortization of deferred financing costs | |||
| Amortization of deferred offering costs | |||
| Purchases of investments | |||
| Proceeds from the sales and repayments of investments | |||
| Changes in operating assets and liabilities: | |||
| (Increase) decrease in due from portfolio companies | |||
| (Increase) decrease in interest receivable | |||
| (Increase) decrease in other assets | |||
| Increase (decrease) in accounts payable, accrued expenses and other liabilities | |||
| Increase (decrease) in base management fee payable | |||
| Increase (decrease) in due to affiliates | |||
| Increase (decrease) in interest payable | |||
| Increase (decrease) in director fees payable | |||
| Net cash used in operating activities | |||
| Financing activities: | |||
| Distributions paid in cash | |||
| Borrowings under credit facility | |||
| Repayments of borrowings under credit facility | |||
| Borrowings of secured borrowings | |||
| Proceeds from the issuance of common units | |||
| Deferred financing costs paid | |||
| Net cash provided by financing activities | |||
| Effect of exchange rate changes on foreign currency | |||
| Net increase (decrease) in cash and cash equivalents | |||
| Cash and cash equivalents, beginning of period | |||
| Cash and cash equivalents, end of period | |||
| Supplemental information: | |||
| Cash paid for interest | |||
| Non-cash financing activities: | |||
| Deferred offering costs incurred | |||
| Deferred financing costs incurred | |||
| Reconciliation to the Statements of Assets and Liabilities | |||
| Cash and cash equivalents |
Loading...